Philadelphia, PA, United States of America

Kong B Tan


Average Co-Inventor Count = 4.5

ph-index = 2

Forward Citations = 57(Granted Patents)


Company Filing History:


Years Active: 2001-2006

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovations of Kong B Tan

Introduction

Kong B Tan is a notable inventor based in Philadelphia, PA (US). He has made significant contributions to the field of medical science, particularly in the development of treatments for various diseases. With a total of 3 patents to his name, his work has the potential to impact many lives.

Latest Patents

Kong B Tan's latest patents include the Tumor necrosis related receptor, TR7. This invention encompasses TR7 polypeptides and polynucleotides, along with methods for producing such polypeptides through recombinant techniques. The patents also detail methods for utilizing TR7 polypeptides and polynucleotides in designing protocols for treating chronic and acute inflammation, arthritis, septicemia, autoimmune diseases, transplant rejection, and various other serious health conditions. These conditions include inflammatory bowel disease, psoriasis, stroke, ischemia, and even cancer, among others.

Career Highlights

Kong B Tan is currently associated with SmithKline Beecham Corporation, where he continues to innovate and contribute to medical research. His work is characterized by a commitment to addressing complex health issues through scientific advancements.

Collaborations

Kong B Tan has collaborated with notable colleagues, including Keith Charles Deen and Peter R Young. These partnerships have likely enhanced the scope and impact of his research.

Conclusion

Kong B Tan's contributions to medical science through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for innovative treatments that could benefit many individuals facing serious health challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…